Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 31.56% is 20% above its 5-year average of 26.26%, near the high end of its 5-year range (-9.87%–36.39%).
As of the fiscal period ended Tuesday, March 31, 2026. 14.09% above its 12-month average of 27.66%.
Reported quarterly operating margin; no daily interpolation.
OPERATING MARGIN
31.56%
OPERATING MARGIN AVG TTM
27.66%
OPERATING MARGIN AVG 3Y
25.76%
OPERATING MARGIN AVG 5Y
28.07%
OPERATING MARGIN AVG 10Y
31.67%
OPERATING MARGIN AVG 15Y
31.11%
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+14.09%
CURRENT VS 3Y AVG
+22.52%
CURRENT VS 5Y AVG
+12.41%
CURRENT VS 10Y AVG
-0.35%
CURRENT VS 15Y AVG
+1.43%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
15.48%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+103.85%
vs the sector median at left
Market Cap
$376.34B
Operating Margin
4.82%
TTM Avg
6.16%
3Y Avg
7.45%
5Y Avg
7.80%
Market Cap
$321.62B
Operating Margin
36.17%
TTM Avg
33.84%
3Y Avg
25.86%
5Y Avg
23.98%
Market Cap
$617.78B
Operating Margin
26.81%
TTM Avg
26.05%
3Y Avg
26.47%
5Y Avg
26.06%
Market Cap
$213.42B
Operating Margin
17.69%
TTM Avg
18.04%
3Y Avg
18.11%
5Y Avg
20.54%
Market Cap
$209.19B
Operating Margin
45.21%
TTM Avg
42.74%
3Y Avg
42.98%
5Y Avg
42.70%
Market Cap
$182.90B
Operating Margin
17.03%
TTM Avg
17.21%
3Y Avg
17.41%
5Y Avg
17.71%
Market Cap
$161.66B
Operating Margin
38.26%
TTM Avg
22.76%
3Y Avg
25.11%
5Y Avg
25.54%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AbbVie Inc. (ABBV) | $443.24B | 31.56% | 27.66% | 25.76% | 28.07% |
| UnitedHealth Group Incorporated (UNH)vs › | $376.34B | 4.82% | 6.16% | 7.45% | 7.80% |
| Merck & Co., Inc. (MRK)vs › | $321.62B | 36.17% | 33.84% | 25.86% | 23.98% |
| Johnson & Johnson (JNJ)vs › | $617.78B | 26.81% | 26.05% | 26.47% | 26.06% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $213.42B | 17.69% | 18.04% | 18.11% | 20.54% |
| Novo Nordisk A/S (NVO)vs › | $209.19B | 45.21% | 42.74% | 42.98% | 42.70% |
| Amgen Inc. (AMGN)vs › | $207.87B | 31.63% | 25.38% | 28.78% | 30.08% |
| Abbott Laboratories (ABT)vs › | $182.90B | 17.03% | 17.21% | 17.41% | 17.71% |
| Gilead Sciences, Inc. (GILD)vs › | $161.66B | 38.26% | 22.76% | 25.11% | 25.54% |
| Pfizer Inc. (PFE)vs › | $142.54B | 23.45% | 25.29% | 24.23% | 24.05% |
Gross Margin
70.7%
Operating Margin
31.6%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-03-31 | 31.56% |
| 2025-12-31 | 34.96% |
| 2025-09-30 | 12.07% |
| 2025-06-30 | 31.73% |
| 2025-03-31 | 27.98% |
| 2024-12-31 | -9.87% |
| 2024-09-30 | 26.49% |
| 2024-06-30 | 27.64% |
| 2024-03-31 | 22.73% |
| 2023-12-31 | 22.34% |
| 2023-09-30 | 16.38% |
| 2023-06-30 | 32.55% |
| 2023-03-31 | 22.64% |
| 2022-12-31 | 36.39% |
| 2022-09-30 | 31.08% |
| 2022-06-30 | 22.59% |
| 2022-03-31 | 34.84% |
| 2021-12-31 | 34.09% |
| 2021-09-30 | 30.02% |
| 2021-06-30 | 31.81% |
| 2021-03-31 | 31.54% |
| 2020-12-31 | 27.08% |
| 2020-09-30 | 25.23% |
| 2020-06-30 | 7.21% |
| 2020-03-31 | 41.80% |
| 2019-12-31 | 45.45% |
| 2019-09-30 | 30.86% |
| 2019-06-30 | 41.19% |
| 2019-03-31 | 38.45% |
| 2018-12-31 | -29.39% |
| 2018-09-30 | 38.36% |
| 2018-06-30 | 33.37% |
| 2018-03-31 | 36.59% |
| 2017-12-31 | 23.18% |
| 2017-09-30 | 38.51% |
| 2017-06-30 | 38.34% |
| 2017-03-31 | 36.82% |
| 2016-12-31 | 34.70% |
| 2016-09-30 | 36.71% |
| 2016-06-30 | 37.00% |
| 2016-03-31 | 38.23% |
| 2015-12-31 | 33.02% |
| 2015-09-30 | 31.71% |
| 2015-06-30 | 33.83% |
| 2015-03-31 | 33.47% |
| 2014-12-31 | -7.61% |
| 2014-09-30 | 19.13% |
| 2014-06-30 | 30.76% |
| 2014-03-31 | 29.61% |
| 2013-12-31 | 30.03% |
| 2013-09-30 | 29.43% |
| 2013-06-30 | 30.97% |
| 2013-03-31 | 30.15% |
| 2012-12-31 | 34.98% |
| 2012-09-30 | 35.40% |
| 2012-06-30 | 31.65% |
| 2012-03-31 | 23.44% |
| 2011-12-31 | 28.35% |
| 2011-09-30 | 1.22% |
| 2011-06-30 | 31.91% |
| 2011-03-31 | 21.16% |
